Portsmouth, United Kingdom

Robert Anthony Newberry

This inventor holds 2 USPTO granted patents. Top assignee: John Wyeth Brother, Limited. Active years: 1976-1978.


% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Portsmouth, EN (1976)
  • Bourne End, EN (1978)

Company Filing History:


Years Active: 1976-1978

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Robert Anthony Newberry: Innovator in Pharmaceutical Chemistry

Introduction

Robert Anthony Newberry is a notable inventor based in Portsmouth, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Newberry's work focuses on compounds that exhibit pharmacological efficacy.

Latest Patents

One of Newberry's latest patents is for 1,3-Diaryl-pyrazol-4-acrylic acid and derivatives. This invention concerns diarylpyrazole lower alkanoic acids and derivatives, which are pharmacologically efficacious as anti-inflammatory agents. The compounds can be represented by a specific formula where one of the components represents hydrogen, while others represent various radicals. Another significant patent involves thiazole derivatives, which are novel compounds exhibiting antilipemic activity. These derivatives have a complex structure that includes aryl radicals and various functional groups.

Career Highlights

Newberry is currently associated with John Wyeth Brother, Limited, where he continues to develop innovative pharmaceutical solutions. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Newberry has collaborated with Brian John Bushell, enhancing the scope and impact of their research efforts.

Conclusion

Robert Anthony Newberry's contributions to pharmaceutical chemistry through his patents highlight his role as an innovator in the field. His work continues to influence the development of effective therapeutic agents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…